Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-07-10

FDA Approved: LABETALOL HCL — Original Application (Par Health USA, LLC)

View source ↗

Summary

The FDA approved the original application for Labetalol hydrochloride (LABETALOL HCL) by Par Health USA, LLC as a generic product for the treatment of hypertens…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LABETALOL HCL (LABETALOL HYDROCHLORIDE)

Snippet

ORIG AP for LABETALOL HCL (LABETALOL HYDROCHLORIDE)